David A. Siegel Health Catalyst, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 17,200 shares of HCAT stock, worth $121,948. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,200
Previous 46,000
62.61%
Holding current value
$121,948
Previous $293,000
52.22%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding HCAT
# of Institutions
170Shares Held
49.7MCall Options Held
2.86MPut Options Held
56.4K-
Black Rock Inc. New York, NY5.43MShares$38.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.58MShares$32.5 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN4.3MShares$30.5 Million3.05% of portfolio
-
Impax Asset Management Group PLC2.55MShares$18.1 Million0.09% of portfolio
-
Daventry Group, LP New York, NY2.42MShares$17.1 Million7.83% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $388M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...